Assignment 06: Life Cycles in Healthcare
Strategic Analysis for Healthcare
Chapter 15
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
1
Life Cycle Analysis
Life cycle analysis assesses products, organizations, or industries by analyzing the current stage in their life cycle.
Although numerous life cycle models exist, researchers have generally identified five main phases in a life cycle:
Birth
Growth
Maturity
Revival
Decline
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
Health Administration Press
Life Cycle Analysis
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
Health Administration Press
Life Cycle Analysis: Birth
Organizations in the birth stage are attempting to establish for the first time a viable product-market strategy.
This is achieved mainly by trial and error as efforts are made to change products and services in a manner that generates distinctive competences.
This generally involves major and frequent product or service innovations and the conscious pursuit of a niche strategy.
Because companies in the birth phase are small and have no established reputation, they do not directly confront their more powerful competitors.
Instead, they find gaps, or niches, in the market that are not being filled, and they fill and defend these niches by making innovations.
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
Health Administration Press
Life Cycle Analysis: Birth
| Phase | Situation | Organization | Innovation & Strategy |
| Birth Phase: | Small firm | Informal structure | Considerable innovation in product lines |
| Young | Undifferentiated | Niche Strategy | |
| Dominated by owner/ manager | Power highly centralized | Substantial risk taking | |
| Homogenous/ placid environment | Crude information processing & decision making methods |
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
Health Administration Press
Life Cycle Analysis: Growth
The emphasis of the growth phase is growth and early diversification:
Product lines are broadened.
Efforts are also devoted to incrementally tailoring products to new markets.
Less stress is placed on major or dramatic product innovations.
“Market segmentation begins to play a role, with managers trying to identify specific subgroups of customers and to make small product or service modifications in order to better serve them.”
“In other words, the niche strategy is often abandoned as broader markets are addressed.”
(Miller and Friesen 1948)
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
Health Administration Press
Life Cycle Analysis: Growth
Organizations in the growth phase are bigger and stronger than those in the birth phase, and they are better able to lobby with various levels of government.
They may also acquire subsidiaries in their efforts to diversify.
An acquisition of this nature “generally takes the form of buying out much smaller competing enterprises in the same industry rather than diversifying into new industries.”
“The acquired firms are usually integrated into the functionally-based structure rather than left as independent divisions” (Miller and Friesen 1984).
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
Health Administration Press
Life Cycle Analysis: Growth
| Phase | Situation | Organization | Innovation & Strategy |
| Growth Phase: | Medium sized | Some formalization of structure | Broadening of product-market scope into closely related areas |
| Older | Functional basis of organization | Incremental innovation in product lines | |
| Multiple share holders | Moderate differentiation | Rapid growth | |
| A more heterogeneous & competitive environment | Somewhat less centralized |
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
Health Administration Press
Life Cycle Analysis: Maturity
Firms in the maturity phase are conservative, “do not perform many major innovations, engage in very few efforts at diversification or acquisition, and fail even to make many incremental changes to the products or services being offered.”
“The tendency, more than in any other phase, is to follow the competition; to wait for competitors to lead the way in innovating and, then, to imitate the innovations if they prove to be necessary” (Miller and Friesen 1984).
Markets in the maturity phase are slightly broader than in the growth phase, and fewer firms opt for a niche strategy.
Firms try to arrange for a stable, negotiated environment by fixing prices and lobbying with the government.
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
Health Administration Press
Life Cycle Analysis: Maturity
The goal appears to be to improve the efficiency and profitability of operations.
This is achieved by
avoiding costly changes in product lines,
ensuring favorable prices via collusion, and
lobbying for barriers to foreign competition.
“A stable and circumscribed product line is sold in traditional markets, the emphasis being upon economical production and the preservation of sales volume” (Miller and Friesen 1984).
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
Health Administration Press
Life Cycle Analysis: Maturity
| Phase | Situation | Organization | Innovation & Strategy |
| Maturity Phase: | Larger | Formal, bureaucratic structure | Consolidation of product- market strategy |
| Even older | Functional basis of organization | Focus on efficiently supplying a well defined market | |
| Dispersed ownership | Moderate differentiation | Conservatism | |
| Heterogeneous & competitive environment | Moderate centralization | Slow growth |
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
Health Administration Press
Life Cycle Analysis: Revival
The revival phase is in many ways the most exciting of the five.
Changes begin to take place in the product-market strategies being followed.
“For example, there are more major and minor product-line and service innovations than in any other period.”
“New markets are entered for the first time as firms become more diversified” (Miller and Friesen 1984).
This diversification sometimes involves the acquisition of firms in different industries.
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
Health Administration Press
Life Cycle Analysis: Revival
Market segmentation further defines discrete parts of the environment, and firms differentiate product lines accordingly.
“Essentially, firms experience dramatic diversification in their products and markets. Their growth does not simply result in an increase in size but an expansion of product-market scope. There is a movement from one market to many, reversing the stagnation of the maturity phase” (Miller and Friesen 1984).
Because of their size, market power, visibility, and occasional acquisitions, some firms in the revival phase lobby with the government to avoid interference with expansion, to obtain protection against imports, and to avoid antitrust lawsuits.
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
Health Administration Press
Life Cycle Analysis: Revival
| Phase | Situation | Organization | Innovation & Strategy |
| Revival Phase: | Very large | Divisional basis of organization | Strategy of product- market diversification; movement into some unrelated markets |
| Very heterogeneous, competitive, dynamic | High differentiation | High level of risk taking & planning | |
| Sophisticated control, scanning, and communications in info. processing; more formal analysis in decision making | Substantial innovation | ||
| Rapid growth |
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
Health Administration Press
Life Cycle Analysis: Decline
Firms in the decline stage react to adversity in their markets by becoming stagnant.
“They try to conserve resources depleted by poor performance by abstaining from product or service innovation. Product lines are rendered antiquated so that it becomes necessary to cut prices to maintain sales” (Miller and Friesen 1984).
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
Health Administration Press
Life Cycle Analysis: Decline
Firms seem to be caught in a vicious circle:
“Their sales are poor because their product lines are unappealing.
This reduces profits and makes for scarcer financial resources,
which in turn cause any significant product line changes to seem too expensive” (Miller and Friesen 1984).
As a result, changes are avoided, and product lines become even more outdated.
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
Health Administration Press
Life Cycle Analysis: Decline
| Phase | Situation | Organization | Innovation & Strategy |
| Decline Phase: | Market size | Formal, bureaucratic structure | Low level of innovation |
| Homogeneous and competitive environment | Mostly functional basis of organization | Price cutting | |
| Moderate differentiation and centralization | Consolidation of product- market | ||
| Less sophisticated info processing systems and decision making methods | Liquidation of subsidiaries | ||
| Risk aversion & conservatism Slow growth |
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
Health Administration Press
Life Cycle Analysis: Decline
Reasons for Decline
Too much debt 28%
Inadequate leadership 17%
Poor planning 14%
Failure to change 11%
Inexperienced management 9%
Not enough revenue 8%
(Business Week 2003)
What do these reasons have in common?
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
Health Administration Press
Life Cycle / Competition Matrix
Dodge, Fullerton, and Robbins (1994) suggest a different way to consider the organizational life cycle.
First, they group organizations into either early stages of development or late stages of development.
They then consider the level of competition the organizations are experiencing.
The resulting four-block matrix displays common critical problems faced by companies in each block.
Strategies can be developed to address the critical problems.
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
Health Administration Press
Life Cycle / Competition Matrix
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
Health Administration Press
Life Cycle / Competition Matrix
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
Health Administration Press
Life Cycle / Competition Matrix
Note that the life cycle chart reflects Toyota, the parent company, and its divisions.
Even though Toyota overall is in maturity, some of its other divisions are still in the growth stage.
Overlaying the life cycle / competition matrix to the life cycle chart reveals that overall Toyota is in “late stage” life cycle with “intense competition.” This suggests “critical problems” of
(a) maintaining market position,
(b) furthering its image via focus & differentiation strategies, and
(c) cost control.
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
Health Administration Press
Exercise
Divide up into groups and create a life cycle chart for your project organization. Include the parent company and any divisions (if there are any).
What are the implications for strategy?
Copyright © 2016 Foundation of the American College of Healthcare Executives. Not for sale.
Health Administration Press
Health Administration Press
Birth Growth Maturity Revival Decline
Size of organization
Time
EARLY STAGELATE STAGE
1. Lack of dependencies and2. Environment neither
LITTLE OR NOconstraints in pursuing goalsthreatening or constraining
COMPETITION
Critical Problems:Critical Problems:
a) Resourcesa) Stabilizing firms position
b) marketing approachb) Formalization & control
c) Formalization of structurec) Stability
d) marketing approach
3. Turbulent environment- may4. Muddling behavior, simply
INTENSEconstrain or dictate actionsreacting
COMPETITION
Critical Problems:Critical Problems:
a) Identify nichesa) Maintain market position
b) Monitor competitionb) Further image via focus &
c) Realignment of the firm differentiation strategies
vis-a-vis the competitionc) Cost control
Source: Dodge, Fullerton & Robbins, Strategic Management Journal, Vol. 15, 121-134 (1994)
5 Forces
| FIVE FORCES | ISSUE | IMPACT ON COMPANY | IMPLICATION FOR STRATEGY |
| Threat of Entry | 1. | ||
| 2. | |||
| 3. | |||
| 4. | |||
| 5. | |||
| Threat of Substitutes | 1. | ||
| 2. | |||
| 3. | |||
| 4. | |||
| 5. | |||
| Power of buyers | 1. | ||
| 2. | |||
| 3. | |||
| 4. | |||
| 5. | |||
| Power of Suppliers | 1. | ||
| 2. | |||
| 3. | |||
| 4. | |||
| 5. | |||
| Intensity of Rivalry | 1. | ||
| 2. | |||
| 3. | |||
| 4. | |||
| 5. | |||
| FORCE | ISSUE | IMPACT ON COMPANY | IMPLICATION FOR STRATEGY |
| Threat of Entry | 1. Government regulation requires licensing and agency approval prior to manufacturing or sale of product. | Company needs a three year lead time in order to obtain approval | Must include strategies to address legal and political issues; keeping competitors at bay during approval lag time, technological obsolescence and leapfrogging during approval period |
| 2. Raw material currently must be sourced from Asia which limits the ability of companies to enter due to higher logistics and transportation costs | Cost, timing, transportation, quality control, political opposition to Asian product may hinder approval process | Must include strategies to address cost, timing, transportation, quality control, political opposition, and sourcing in the US | |
| 3. Existing competitors have high profit margins and a willingness and capability to engage in a prolonged price war designed to drive a new entrant in the market out. | A price war would reduce the projected profit margins and make the market undesirable to enter | Strategy must address a method to develop a low cost manufacturing and distribution system and provide funding to survive a price war | |
| 4. Ability of dominant players to buy smaller players, thus consolidating costs and expanding market share. | Industry consolidation could create one or two "10,000 lb gorillas" that could dominate the industry and our ability to obtain contracts | Strategy must address proactive defense to industry consolidation or develop a method to compete in a consolidated industry | |
| 5. Exclusive supplier contracts are in place with major buyers which currently lock out new suppliers | Company may not be immediately able to enter into contracts to supply until existing exclusive contracts by competitors expire | Must include strategies to challenge the propriety of the exclusive supplier agreements, find a way around such contracts, or enable company to jump in when such contracts expire | |
| Threat of Substitutes | 1. | ||
| 2. | |||
| 3. | |||
| 4. | |||
| 5. | |||
| Power of buyers | 1. | ||
| 2. | |||
| 3. | |||
| 4. | |||
| 5. | |||
| Power of Suppliers | 1. | ||
| 2. | |||
| 3. | |||
| 4. | |||
| 5. | |||
| Intensity of Rivalry | 1. | ||
| 2. | |||
| 3. | |||
| 4. | |||
| 5. |
PEST
| P.E.S.T. | ISSUE | IMPACT ON COMPANY | IMPLICATION FOR STRATEGY |
| Political | 1. | ||
| 2. | |||
| 3. | |||
| 4. | |||
| 5. | |||
| Economic | 1. | ||
| 2. | |||
| 3. | |||
| 4. | |||
| 5. | |||
| Social | 1. | ||
| 2. | |||
| 3. | |||
| 4. | |||
| 5. | |||
| Technological | 1. | ||
| 2. | |||
| 3. | |||
| 4. | |||
| 5. | |||
| P.E.S.T. | ISSUE | IMPACT ON COMPANY | IMPLICATION FOR STRATEGY |
| Social | 1. | ||
| 2. | |||
| 3. | |||
| 4. | |||
| 5. |
Competative
| Some Possible Broad Categories and Sub-Catagories | Analysis example using a "YES" / "NO" method | Identify the key broad catagories for your industry | Your Company | Competator | Competator | Competator | Industry | ||||||||||||||
| Product related | Financial | Distribution System: | Our Co. | Alpha Co. | Beta Co | Omega Co. | Industry | 1. | Category | 1. | 2. | 3. | Implications for your company's strategy: | ||||||||
| Product quality | Operating ratio | Just in time delivery system | YES | NO | NO | YES | NO | 2. | 1. | 1. | |||||||||||
| Product price point | Inventory turnover | Vendor managed inventory | YES | YES | NO | YES | YES | 3. | a. | 2. | |||||||||||
| New product development rate | Number of days of sales outstanding | Captive trucking division | YES | YES | YES | YES | YES | 4 | b. | 3. | |||||||||||
| Product replacement cycle | Gross margin ratio | Unionized | YES | NO | NO | NO | NO | 5. | c. | 4. | |||||||||||
| Inovation | Return on equity | e. | 5. | ||||||||||||||||||
| Product image / reputation | Return on assets | f. | 6. | ||||||||||||||||||
| Debt-to-equity ratio | Analysis example using a scoring scale method | g. | 7. | ||||||||||||||||||
| Sales Related | Earnings per share | Product | Our Co. | Alpha Co. | Beta Co | Omega Co. | Industry | 8. | |||||||||||||
| Market share | Product quality | 1 | 2 | 2 | 5 | 3 | 2. | 9. | |||||||||||||
| Distribution network | Employee Related | Product price point | 3 | 1 | 2 | 5 | 1 | a. | 10. | ||||||||||||
| Sales growth % | Average number of employees | New product development rate | 1 | 4 | 2 | 5 | 3 | b. | |||||||||||||
| Corporate Image | Annual revenue per employee | Product replacement cycle | 1 | 4 | 3 | 5 | 3 | c. | |||||||||||||
| Customer loyalty | Annual compensation per employee | 1 = Superior; 5 = Poor | e. | ||||||||||||||||||
| Service and sales policies | Flexibility of Organizational Structure | f. | |||||||||||||||||||
| Advertising | Ability to Attract & Retain the best people | g. | |||||||||||||||||||
| Analysis example using a numeric data reporting method | |||||||||||||||||||||
| Manufacturing Related | Distribution Related | Financial | Our Co. | Alpha Co. | Beta Co | Omega Co. | Industry | 3. | |||||||||||||
| Annual maintenance & repair expense | Just in time delivery system | Number of days of sales outstanding | 130 | 76 | 98 | 45 | 67 | a. | |||||||||||||
| Downtime | Vendor managed inventory | Gross margin % | 53 | 48 | 67 | 33 | 42 | b. | |||||||||||||
| Number of manufacturing plants | Captive trucking division | Return on equity % | 15 | 13 | 13 | 3 | 7 | c. | |||||||||||||
| Location of manufacturing plants | Unionized | Earnings per share | .32 | .53 | .10 | .27 | .33 | e. | |||||||||||||
| Competition’s capacity utilization | f. | ||||||||||||||||||||
| Technological capability | g. | ||||||||||||||||||||
| Vertical integration | Analysis example using a force ranking method | ||||||||||||||||||||
| Sales | Our Co. | Alpha Co. | Beta Co | Omega Co. | Median | 4. | |||||||||||||||
| Some Possible Broad Catagories | Market share | 1 | 2 | 3 | 4 | 2.5 | a. | ||||||||||||||
| Product related | Sales growth % | 2 | 4 | 3 | 1 | 2.5 | b. | ||||||||||||||
| Financial Related | Corporate Image | 2 | 4 | 1 | 3 | 2.5 | c. | ||||||||||||||
| Sales Related | Customer loyalty | 1 | 3 | 2 | 4 | 2.5 | e. | ||||||||||||||
| Employee Related | f. | ||||||||||||||||||||
| Manufacturing Related | g. | ||||||||||||||||||||
| Distribution Related | |||||||||||||||||||||
| 5. | |||||||||||||||||||||
| a. | |||||||||||||||||||||
| b. | |||||||||||||||||||||
| c. | |||||||||||||||||||||
| e. | |||||||||||||||||||||
| f. | |||||||||||||||||||||
| g. |
SWOT
| Your company | Competitor 1 | Competitor 2 | Competitor 3 | EFE Analysis | EFE Analysis | IFE Analysis | IFE Analysis | ||||||||||||||||||||||||||||||||
| Internal: | Strengths | Weaknesses | Internal: | Strengths | Weaknesses | IMPLICATIONS FOR STRATEGY | Strengths | Opportunities | Weight | Rating | Score | Opportunities | Weight | Rating | Score | Strengths | Weight | Rating | Score | Strengths | Weight | Rating | Score | ||||||||||||||||
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | Products expansion | 0.100 | 4 | 0.400 | 1 | 1 | Marketing Philosophy | 0.100 | 4 | 0.400 | 1 | |||||||||||||||||||||
| External: | Opportunities | Threats | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | Stock growth | 0.025 | 2 | 0.050 | 2 | 2 | Social Responsibility | 0.100 | 3 | 0.300 | 2 | ||||||||||||||||||
| 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | More exposure | 0.100 | 2 | 0.200 | 3 | 3 | Creative Products | 0.100 | 4 | 0.400 | 3 | |||||||||||||||||||||
| 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | Move towards globalization | 0.025 | 1 | 0.025 | 4 | 4 | Diverse Product Line | 0.025 | 4 | 0.100 | 4 | |||||||||||||||||||||
| 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | More stadium contracts | 0.025 | 2 | 0.050 | 5 | 5 | Mass Customization | 0.050 | 3 | 0.150 | 5 | |||||||||||||||||||||
| 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | Expand target market | 0.100 | 2 | 0.200 | 6 | 6 | Product Specialization | 0.030 | 4 | 0.120 | 6 | |||||||||||||||||||||
| 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | License agreements | 0.050 | 3 | 0.150 | 7 | 7 | Ethics Program | 0.005 | 3 | 0.015 | 7 | |||||||||||||||||||||
| 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | Company growth | 0.025 | 2 | 0.050 | 8 | 8 | Quality Products | 0.090 | 3 | 0.270 | 8 | |||||||||||||||||||||
| 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 0.000 | 9 | ||||||||||||||||||||||||||||
| 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 0.000 | 10 | ||||||||||||||||||||||||||||
| External: | Opportunities | Threats | Weaknesses | Rating Scale: 4= major strength; 3= minor strength | Rating Scale: 4= major strenght; 3= minor strenght | ||||||||||||||||||||||||||||||||||
| 1 | 1 | 1 | 1 | 1 | 1 | Threats | Threats | Weaknesses | Weaknesses | ||||||||||||||||||||||||||||||
| 2 | 2 | 2 | 2 | 2 | 2 | 1 | Multiple competitors | 0.100 | 2 | 0.200 | 1 | 1 | Inexperienced mgmt team | 0.050 | 1 | 0.050 | 1 | ||||||||||||||||||||||
| 3 | 3 | 3 | 3 | 3 | 3 | 2 | Dependency on sugar cane | 0.075 | 3 | 0.225 | 2 | 2 | Expensive Retail price structure | 0.025 | 2 | 0.050 | 2 | ||||||||||||||||||||||
| 4 | 4 | 4 | 4 | 4 | 4 | 3 | Suppliers have the power | 0.025 | 2 | 0.050 | 3 | 3 | Weak marketing processes | 0.075 | 1 | 0.075 | 3 | ||||||||||||||||||||||
| 5 | 5 | 5 | 5 | 5 | 5 | 4 | Recent lawsuit | 0.025 | 2 | 0.050 | 4 | 4 | Limited Distribution | 0.075 | 1 | 0.075 | 4 | ||||||||||||||||||||||
| 6 | 6 | 6 | 6 | 6 | 6 | 5 | License agreements | 0.075 | 3 | 0.225 | 5 | 5 | Limited Financial Capability | 0.025 | 2 | 0.050 | 5 | ||||||||||||||||||||||
| 7 | 7 | 7 | 7 | 7 | 7 | 6 | Seasonality of sales | 0.050 | 1 | 0.050 | 6 | 6 | Small company | 0.025 | 2 | 0.050 | 6 | ||||||||||||||||||||||
| 8 | 8 | 8 | 8 | 8 | 8 | 7 | Dependence on suppliers | 0.050 | 3 | 0.150 | 7 | 7 | Informalities of Company | 0.050 | 1 | 0.050 | 7 | ||||||||||||||||||||||
| 9 | 9 | 9 | 9 | 9 | 9 | 8 | Dependence on contract packers | 0.100 | 3 | 0.300 | 8 | 8 | Little Brand Recognition | 0.100 | 1 | 0.100 | 8 | ||||||||||||||||||||||
| 10 | 10 | 10 | 10 | 10 | 10 | 9 | Dependence on distributors | 0.050 | 3 | 0.150 | 9 | 9 | Collection Practices for receivables | 0.075 | 1 | 0.075 | 9 | ||||||||||||||||||||||
| Opportunities | 10 | 10 | 10 | 0.000 | 10 | ||||||||||||||||||||||||||||||||||
| 1 | 1 | 1 | 1 | Total Weight: | 1.000 | Total Score: | 2.525 | Total Weight: | Total Score: | Rating Scale: 1= major weakness 2= minor weakness | Rating Scale: 1= major weakness 2= minor weakness | ||||||||||||||||||||||||||||
| STRENGHTS | WEAKNESSES | 2 | 2 | 2 | 2 | Rating Scale: | Rating Scale: | Total Weight: | 1.000 | Total Score: | 2.330 | Total Weight: | Total Score: | ||||||||||||||||||||||||||
| OPPORTUNITIES | THREATS | 3 | 3 | 3 | 3 | 4 = Current Response is Superior | 4 = Current Response is Superior | ||||||||||||||||||||||||||||||||
| 4 | 4 | 4 | 4 | 3 = Current Response is Above Average | 3 = Current Response is Above Average | ||||||||||||||||||||||||||||||||||
| 5 | 5 | 5 | 5 | 2 = Current Response is Average | 2 = Current Response is Average | ||||||||||||||||||||||||||||||||||
| 6 | 6 | 6 | 6 | 1 = Current Response is Poor | 1 = Current Response is Poor | ||||||||||||||||||||||||||||||||||
| 7 | 7 | 7 | 7 | ||||||||||||||||||||||||||||||||||||
| 8 | 8 | 8 | 8 | ||||||||||||||||||||||||||||||||||||
| 9 | 9 | 9 | 9 | ||||||||||||||||||||||||||||||||||||
| 10 | 10 | 10 | 10 | ||||||||||||||||||||||||||||||||||||
| Threats | |||||||||||||||||||||||||||||||||||||||
| 1 | 1 | 1 | 1 | ||||||||||||||||||||||||||||||||||||
| 2 | 2 | 2 | 2 | ||||||||||||||||||||||||||||||||||||
| 3 | 3 | 3 | 3 | ||||||||||||||||||||||||||||||||||||
| 4 | 4 | 4 | 4 | ||||||||||||||||||||||||||||||||||||
| 5 | 5 | 5 | 5 | ||||||||||||||||||||||||||||||||||||
| 6 | 6 | 6 | 6 | ||||||||||||||||||||||||||||||||||||
| 7 | 7 | 7 | 7 | ||||||||||||||||||||||||||||||||||||
| 8 | 8 | 8 | 8 | ||||||||||||||||||||||||||||||||||||
| 9 | 9 | 9 | 9 | ||||||||||||||||||||||||||||||||||||
| 10 | 10 | 10 | 10 |
IE Matrix
| Weighted IFE Score | Weighted IFE Score | ||||||||||
| Strong 3.0- 4.0 | Average 2.0 to 2.99 | Weak 1.0 to 1.99 | Strong 3.0- 4.0 | Average 2.0 to 2.99 | Weak 1.0 to 1.99 | ||||||
| Weighted EFE Score | High 3.0- 4.0 | A | A | B | Weighted EFE Score | High 3.0- 4.0 | A | A | B | ||
| Medium 2.0 to 2.99 | A | B | C | Medium 2.0 to 2.99 | A | B | C | ||||
| Low 1.0 to 1.99 | B | C | C | Low 1.0 to 1.99 | B | C | C | ||||
| Implied Strategies- | |||||||||||
| A | Grow and Build | Integration strategies, intensive strategies | |||||||||
| B | Hold and Maintain | Market penetration, product development, joint venture | |||||||||
| C | Harvest or divest | Retrenchment, divesturature , liquidation | |||||||||
| Integration Strategies | |||||||||||
| Forward integration- Ownership or increased control over distributors or retailers. | |||||||||||
| Backward integration- Ownership or increased control over suppliers. | |||||||||||
| Horizontal integration- Ownership or increased control over competitors. | |||||||||||
| Intensive Strategies | |||||||||||
| Market Development- New or present products into new areas. | |||||||||||
| Product Development- Improving or Modification of product for increased sales. | |||||||||||
| Market Penetration- Increased share for present products by increased effort. | |||||||||||
| Defensive Strategies | |||||||||||
| Joint Venture- When two or more firms join & create a third co-owned firm | |||||||||||
| Retrenchment- Organization regroups using cost and asset reduction techniques | |||||||||||
| Divestiture- Selling a product line, division, or business unit | |||||||||||
| Liquidation- Selling all of the company assets. | |||||||||||
| Diversification Strategies | |||||||||||
| Concentric Diversification Adding new but related products. | |||||||||||
| Horizontal Diversification Adding new Unrelated products for present customers. Firm knows customers. | |||||||||||
| Conglomerate Diversification Adding new unrelated products. Firm not familiar with customer base. | |||||||||||
| Summary | |||||||||||
| Mergers/Buyouts. | |||||||||||
| Mergers Buy similar sized companies. | |||||||||||
| Leveraged Buyouts Shareholders are bought out. | |||||||||||
| Generic Strategies | |||||||||||
| Cost Leadership strategies Striving to be the low cost provider. ~WalMart | |||||||||||
| Differentiation Strategies To stand out,~service,performance,useful life,ease of use. | |||||||||||
| Focus Strategies Concentration after certain customer or area attributes. |
Financial
| RATIO | CALCULATION | WHAT IT TELLS US | RATIO | Year 1 | Year 2 | % + / - | Year 3 | % + / - | Year 4 | % + / - | Year 5 | % + / - | RATIO | Company | Industry | % + / - | Competitor 1 | % + / - | Competitor 2 | % + / - | Competator3 | % + / - | |||||
| Liquidity Ratios | Liquidity Ratios | Liquidity Ratios | |||||||||||||||||||||||||
| Current Ratio | Current assets | If a Firm's short-term assets are readily available to pay off its short-term liabilities | Current Ratio | Current Ratio | |||||||||||||||||||||||
| Current liabilities | Quick or Acid-Test Ratio | Quick or Acid-Test Ratio | |||||||||||||||||||||||||
| Leverage Ratios | Leverage Ratios | ||||||||||||||||||||||||||
| Quick or Acid-Test Ratio | Current assets – inventory | The amount of the most liquid current assets available to cover current liabilities | Debt-to-Total-Asset Ratio | Debt-to-Total-Asset Ratio | |||||||||||||||||||||||
| Current liabilities | Debt-to-Equity Ratio | Debt-to-Equity Ratio | |||||||||||||||||||||||||
| Leverage Ratios | Long-Term Debt-to-Equity | Long-Term Debt-to-Equity | |||||||||||||||||||||||||
| Debt-to-Total-Asset Ratio | Total liabilities | The amount of leverage being used by a company. | Times-Interest-Earned Ratio | Times-Interest-Earned Ratio | |||||||||||||||||||||||
| Total assets | Activity Ratios | Activity Ratios | |||||||||||||||||||||||||
| Inventory-Turnover Ratio | Inventory-Turnover Ratio | ||||||||||||||||||||||||||
| Debt-to-Equity Ratio | Total liabilities | Measures how much debt a firm has compared to shareholders equity | Total-Asset Turnover | Total-Asset Turnover | |||||||||||||||||||||||
| Shareholders Equity | Fixed-Asset Turnover | Fixed-Asset Turnover | |||||||||||||||||||||||||
| Average Collection Period | Average Collection Period | ||||||||||||||||||||||||||
| Long-Term Debt-to-Equity | long term liabilities | Measures how much long term debt a firm has compared to shareholders equity | Profitability Ratios | Profitability Ratios | |||||||||||||||||||||||
| Shareholders Equity | Gross Profit Margin | Gross Profit Margin | |||||||||||||||||||||||||
| Operating Profit Margin | Operating Profit Margin | ||||||||||||||||||||||||||
| Times-Interest-Earned Ratio | EBIT | Determines how easily a company can pay interest expenses on outstanding debt | Net Profit Margin | Net Profit Margin | |||||||||||||||||||||||
| Interest charges | Return on Total Asset (ROA) | Return on Total Asset (ROA) | |||||||||||||||||||||||||
| Activity Ratios | Return on Stockholders’ Equity | Return on Stockholders’ Equity | |||||||||||||||||||||||||
| Inventory-Turnover Ratio | Sales | How long sales inventory waits to be sold | Return on Capital Employed | Return on Capital Employed | |||||||||||||||||||||||
| Inventory | Earnings per Share | Earnings per Share | |||||||||||||||||||||||||
| EBITDA | EBITDA | ||||||||||||||||||||||||||
| Total-Asset Turnover | Sales | The relationship between assets and revenue | Growth Ratios | Growth Ratios | |||||||||||||||||||||||
| Total assets | Sales increase | Sales increase | |||||||||||||||||||||||||
| Earnings per Share | Earnings per Share | ||||||||||||||||||||||||||
| Fixed-Asset Turnover | Sales | The relationship between fixed assets and revenue | Dividends payout ratio | Dividends payout ratio | |||||||||||||||||||||||
| Fixed assets | Valuation | Valuation | |||||||||||||||||||||||||
| P/E Ratio | P/E Ratio | ||||||||||||||||||||||||||
| Average Collection Period | Receivables | How long it takes a firm to collect payment from it's customers | Price to Book ratio | Price to Book ratio | |||||||||||||||||||||||
| Sales per day | PEG Ratio | PEG Ratio | |||||||||||||||||||||||||
| Profitability Ratios | Profit margin on sales | Profit margin on sales | |||||||||||||||||||||||||
| Gross Profit Margin | Gross profit | The amount of gross profit as a percent of sales | Return on net worth | Return on net worth | |||||||||||||||||||||||
| Net sales | January 1st stock price | January 1st stock price | |||||||||||||||||||||||||
| Net Income | Net Income | ||||||||||||||||||||||||||
| Operating Profit Margin | Operating profit | The amount of operating profit as a percent of sales | Gross income | Gross income | |||||||||||||||||||||||
| Net sales | |||||||||||||||||||||||||||
| Net Profit Margin | Net income | The amount of net profit as a percent of sales | |||||||||||||||||||||||||
| Net sales | |||||||||||||||||||||||||||
| Return on Total Asset (ROA) | Net income | How well management is using the company's assets to earn a profit. | |||||||||||||||||||||||||
| Total assets | |||||||||||||||||||||||||||
| Return on Stockholders’ Equity | Net income | Measures how much shareholders earned on their investment in the firm | |||||||||||||||||||||||||
| Shareholders equity | |||||||||||||||||||||||||||
| Return on Capital Employed | EBIT | Indicates the efficiency and profitability of a company's capital investments | |||||||||||||||||||||||||
| Total assets-current liabilities | |||||||||||||||||||||||||||
| Earnings per Share | Net income- preferred stock dividends | profit per share of common stock outstanding | |||||||||||||||||||||||||
| Shares outstanding | |||||||||||||||||||||||||||
| EBITDA | profit per share of common stock outstanding adjusted for interest, taxes, depreciation & amortization | ||||||||||||||||||||||||||
| Growth Ratios | |||||||||||||||||||||||||||
| Sales increase | Current year sales | Percent increase in sales year over year | |||||||||||||||||||||||||
| Prior year sale | |||||||||||||||||||||||||||
| Earnings per Share | Net income- preferred stock dividends | How much profit is earned for each share of common stock | |||||||||||||||||||||||||
| Average outstanding shares | |||||||||||||||||||||||||||
| Dividends payout ratio | Dividends per common share | The portion of a company's earnings paid relative to each common share | |||||||||||||||||||||||||
| Earnings per share | |||||||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||
| P/E Ratio | Price per share | how much investors are willing to pay per dollar of earnings. | |||||||||||||||||||||||||
| Earnings per share | |||||||||||||||||||||||||||
| Price to Book ratio | Price per share | Compares a firm's market value to its book value | |||||||||||||||||||||||||
| Total assets-intangible assets & liabilities | |||||||||||||||||||||||||||
| PEG Ratio | P/E Ratio | Determines a stock's value while taking into account earnings growth (<1= undervalued) | |||||||||||||||||||||||||
| Annual EPS growth | |||||||||||||||||||||||||||
| Profit margin on sales | Net income | How much profit a company makes on it's sales | |||||||||||||||||||||||||
| Sales | |||||||||||||||||||||||||||
| Return on net worth | Net income | Profit as related to the firm's net worth | |||||||||||||||||||||||||
| Net worth |
BCG
| High | STAR | QUESTION MARK | High | High | A | A | B | ||||||||||||||||
| MARKET | |||||||||||||||||||||||
| GROWTH | |||||||||||||||||||||||
| RATE | MARKET | MARKET | A | B | C | ||||||||||||||||||
| ATTRACTIVENESS | ATTRACTIVENESS | ||||||||||||||||||||||
| Medium | |||||||||||||||||||||||
| Low | CASH COWS | DOGS | |||||||||||||||||||||
| High | Low | B | C | C | |||||||||||||||||||
| RELATIVE MARKET SHARE | |||||||||||||||||||||||
| High | |||||||||||||||||||||||
| Low | Low | ||||||||||||||||||||||
| High | Low | High | Medium | Low | |||||||||||||||||||
| BUSINESS STRENGTH | BUSINESS STRENGTH | ||||||||||||||||||||||
| MARKET | |||||||||||||||||||||||
| GROWTH | |||||||||||||||||||||||
| RATE | General Strategies Based on Matrix Location: | ||||||||||||||||||||||
| A | Grow & Build: | Integration strategies, intensive strategies | |||||||||||||||||||||
| B | Hold & Maintain: | Market penetration, product development, joint venture | |||||||||||||||||||||
| C | Harvest & divest: | Retrenchment, divesturature , liquidation | |||||||||||||||||||||
| Low | |||||||||||||||||||||||
| High | Low | ||||||||||||||||||||||
| RELATIVE MARKET SHARE |
Life Cycle
| EARLY STAGE | LATE STAGE | Reasons For Decline | |||||||||||||||||
| 1. Lack of dependencies and | 2. Environment neither | Too much Debt | 28% | ||||||||||||||||
| LITTLE OR NO | constraints in pursuing goals | threatening or constraining | Inadequate Leadership | 17% | |||||||||||||||
| COMPETITION | Poor Planning | 14% | |||||||||||||||||
| Critical Problems: | Critical Problems: | Failure to Change | 11% | ||||||||||||||||
| a) Resources | a) Stabilizing firms position | Inexperienced Management | 9% | ||||||||||||||||
| b) marketing approach | b) Formalization & control | Not Enough Revenue | 8% | ||||||||||||||||
| c) Formalization of structure | c) Stability | ||||||||||||||||||
| d) marketing approach | *Source: Buccino and Associates: Seton Hall University, as reported in August 25, 2003, Business Week. | ||||||||||||||||||
| 3. Turbulent environment- may | 4. Muddling behavior, simply | ||||||||||||||||||
| INTENSE | constrain or dictate actions | reacting | |||||||||||||||||
| COMPETITION | |||||||||||||||||||
| Critical Problems: | Critical Problems: | ||||||||||||||||||
| a) Identify niches | a) Maintain market position | ||||||||||||||||||
| b) Monitor competition | b) Further image via focus & | ||||||||||||||||||
| c) Realignment of the firm | differentiation strategies | ||||||||||||||||||
| vis-a-vis the competition | c) Cost control | ||||||||||||||||||
| Source: Dodge, Fullerton & Robbins, Strategic Management Journal, Vol. 15, 121-134 (1994) | CORPORATE LIFE CYCLE | ||||||||||||||||||
| Phase | Situation | Organization | Innovation & Strategy | ||||||||||||||||
| Birth Phase: | Small firm | Informal structure | Considerable innovation in product lines | ||||||||||||||||
| Young | Undifferiented | Niche Strategy | |||||||||||||||||
| Dominated by owner/ manager | Power highly centralized | Substantial risk taking | |||||||||||||||||
| Homogenous/ placid environment | Crude information processing & decision making methods | ||||||||||||||||||
| Growth Phase: | Medium sized | Some formalization of structure | Broadening of product-market scope into closely related areas | ||||||||||||||||
| Older | Functional basis of organization | Incremental innovation in product lines | |||||||||||||||||
| Multiple share holders | Moderate differentiation | Rapid growth | |||||||||||||||||
| A more heterogeneous & competitive environment | Somewhat less centralized | ||||||||||||||||||
| Initial development of formal information processing & decision making tools | |||||||||||||||||||
| Maturity Phase: | Larger | Formal, bureaucratic structure | Consolidation of product- market strategy | ||||||||||||||||
| Even older | Functional basis of organization | Focus on efficiently supplying a well defined market | |||||||||||||||||
| Dispersed ownership | Moderate differentiation | Conservatism | |||||||||||||||||
| heterogeneous & competitive environment | Moderate centralization | Slow growth | |||||||||||||||||
| Information processing & decision making same as growth stage | |||||||||||||||||||
| Revival Phase: | Very large | Divisional basis of organization | Strategy of product- market diversification; movement into some unrelated markets | ||||||||||||||||
| Very heterogeneous, competitive, dynamic | High differentiation | High level of risk taking & planning | |||||||||||||||||
| Sophisticated control, scanning, and communications in info. processing; more formal analysis in decision making | Substantial innovation | ||||||||||||||||||
| Rapid growth | |||||||||||||||||||
| Decline Phase: | Market size | Formal, bureaucratic structure | Low level of innovation | ||||||||||||||||
| Homogeneous and competitive environment | Mostly functional basis of organization | Price cutting | |||||||||||||||||
| Moderate differentiation and centralization | Consolidation of product- market | ||||||||||||||||||
| Less sophisticated info processing systems and decision making methods | Liquidation of subsidiaries | ||||||||||||||||||
| Risk aversion & conservatism | |||||||||||||||||||
| Slow growth | |||||||||||||||||||
| Source: Miler and Friesen, Management Science, Vol. 30, No. 10 (Oct., 1984), pp. 1161-1183 |
Culture
| CULTURAL ASPECT | SCORE (+5 TO -5) | |||
| Are control and reward mechanisms effective? | ||||
| Are job responsibilities clearly understood? | ||||
| Are company policies & procedures appropriate and effective? | ||||
| Capacity for retaining personnel | New | |||
| Clearly articulated and shared mission | ||||
| Cohesiveness and collaboration | ||||
| Degree of innovation | ||||
| Do employees have latitude in job execution? | ||||
| Do managers delegate authority? | ||||
| Do the leaders live the values and walk the talk? | Existing | |||
| Does the organization aggressively pursue change and innovation? | ||||
| Does the organization effectively deploy employee teams through the company? | ||||
| Employee attitudes | ||||
| Employee empowerment | ||||
| Employee Motivation | ||||
| Employee participation in decisions | ||||
| Enabling others to act | ||||
| Encouraging the heart | ||||
| Enforcement of policies | ||||
| Effective Human Resource Management | ||||
| Innovation and change to process | ||||
| Is employee compensation fair / competitive? | ||||
| Is employee morale high? | ||||
| Is power centralized or shared throughout the organization | ||||
| Is the organization’s structure appropriate for the proposed strategy? | ||||
| Is there open and constant communication from management to employees | ||||
| Key executive’s style | ||||
| Lifecycle stage of organization | ||||
| Openness and trust | ||||
| Opportunities for employee growth & development | ||||
| Organizational climate | ||||
| Organizational Structure | ||||
| Passion for the product or company | ||||
| Perception of job security | ||||
| Recognition of individuals | ||||
| Rewards for performance | ||||
| Risk tolerance | ||||
| Sense of belonging | ||||
| Sense of urgency | ||||
| Shared Vision | ||||
| Union Relations | ||||
| What are the founder’s beliefs & what influence do they have? |
Ansoff
| New | New | Market Development | Diversification | ||||||
| (Risk=Moderate) | (Risk=High) | ||||||||
| 1 | 1 | ||||||||
| 2 | 2 | ||||||||
| 3 | 3 | ||||||||
| 4 | 4 | ||||||||
| Markets | 5 | 5 | |||||||
| Market Penetration | Product Development | ||||||||
| Existing | Existing | (Risk= Low) | (Risk=Moderate) | ||||||
| 1 | 1 | ||||||||
| 2 | 2 | ||||||||
| 3 | 3 | ||||||||
| 4 | 4 | ||||||||
| 5 | 5 | ||||||||
| Existing | New | ||||||||
| Products & Services |
Sheet1
| European Expansion | Product Expansion | European Expansion | Product Expansion | Strategy 1 | Strategy 2 | Strategy 3 | Strategy 4 | ||||||||||||||||||||
| Opportunities | Weight | Attractiveness Score | Total Attractiveness Score | Attractiveness Score | Total Attractiveness Score | Opportunities | Weight | Attractiveness Score | Total Attractiveness Score | Attractiveness Score | Total Attractiveness Score | Opportunities | Weight | Attractiveness Score | Total Attractiveness Score | Attractiveness Score | Total Attractiveness Score | Attractiveness Score | Total Attractiveness Score | Attractiveness Score | Total Attractiveness Score | ||||||
| 1 | Products expansion | 0.100 | 2 | 0.200 | 4 | 0.400 | 3 | More exposure | 0.100 | 4 | 0.400 | 2 | 0.200 | 1 | |||||||||||||
| 2 | Stock growth | 0.025 | 4 | 0.100 | 4 | 0.100 | 2 | ||||||||||||||||||||
| 3 | More exposure | 0.100 | 4 | 0.400 | 2 | 0.200 | 3 | ||||||||||||||||||||
| 4 | Move towards globalization | 0.025 | 4 | 0.100 | 0 | 0.000 | 4 | ||||||||||||||||||||
| 5 | More stadium contracts | 0.025 | 1 | 0.025 | 1 | 0.025 | 5 | ||||||||||||||||||||
| 6 | Expand target market | 0.100 | 4 | 0.400 | 3 | 0.300 | 6 | ||||||||||||||||||||
| 7 | License agreements | 0.050 | 2 | 0.100 | 1 | 0.050 | 7 | ||||||||||||||||||||
| 8 | Company growth | 0.025 | 4 | 0.100 | 4 | 0.100 | 8 | ||||||||||||||||||||
| 9 | |||||||||||||||||||||||||||
| Threats | Threats | ||||||||||||||||||||||||||
| 1 | Multiple competitors | 0.100 | 2 | 0.200 | 3 | 0.300 | 1 | ||||||||||||||||||||
| 2 | Dependency on sugar cane | 0.075 | 0 | 0.000 | 0 | 0.000 | 2 | ||||||||||||||||||||
| 3 | Suppliers have the power | 0.025 | 2 | 0.050 | 2 | 0.050 | 3 | ||||||||||||||||||||
| 4 | Recent lawsuit | 0.025 | 0 | 0.000 | 0 | 0.000 | 4 | ||||||||||||||||||||
| 5 | License agreements | 0.075 | 2 | 0.150 | 2 | 0.150 | 5 | ||||||||||||||||||||
| 6 | Seasonality of sales | 0.050 | 4 | 0.200 | 3 | 0.150 | 6 | ||||||||||||||||||||
| 7 | Dependence on suppliers | 0.050 | 2 | 0.100 | 1 | 0.050 | 7 | ||||||||||||||||||||
| 8 | Dependence on contract packers | 0.100 | 3 | 0.300 | 0 | 0.000 | 8 | ||||||||||||||||||||
| 9 | Dependence on distributors | 0.050 | 3 | 0.150 | 2 | 0.100 | 9 | ||||||||||||||||||||
| 10 | |||||||||||||||||||||||||||
| Total Weight: | 1.000 | Total Weight: | |||||||||||||||||||||||||
| Strengths | Strengths | ||||||||||||||||||||||||||
| 1 | Marketing Philosophy | 0.100 | 3 | 0.300 | 4 | 0.400 | 1 | ||||||||||||||||||||
| 2 | Social Responsibility | 0.100 | 2 | 0.200 | 2 | 0.200 | 2 | ||||||||||||||||||||
| 3 | Creative Products | 0.100 | 4 | 0.400 | 4 | 0.400 | 3 | ||||||||||||||||||||
| 4 | Diverse Product Line | 0.025 | 4 | 0.100 | 4 | 0.100 | 4 | ||||||||||||||||||||
| 5 | Mass Customization | 0.050 | 3 | 0.150 | 2 | 0.100 | 5 | ||||||||||||||||||||
| 6 | Product Specialization | 0.030 | 3 | 0.090 | 3 | 0.090 | 6 | ||||||||||||||||||||
| 7 | Ethics Program | 0.005 | 1 | 0.005 | 1 | 0.005 | 7 | ||||||||||||||||||||
| 8 | Quality Products | 0.090 | 3 | 0.270 | 3 | 0.270 | 8 | ||||||||||||||||||||
| 9 | |||||||||||||||||||||||||||
| Weaknesses | Weaknesses | ||||||||||||||||||||||||||
| 1 | Inexperienced mgmt team | 0.050 | 1 | 0.050 | 1 | 0.050 | 1 | ||||||||||||||||||||
| 2 | Expensive Retail price structure | 0.025 | 2 | 0.050 | 2 | 0.050 | 2 | ||||||||||||||||||||
| 3 | Weak marketing processes | 0.075 | 2 | 0.150 | 1 | 0.075 | 3 | ||||||||||||||||||||
| 4 | Limited Distribution | 0.075 | 4 | 0.300 | 2 | 0.150 | 4 | ||||||||||||||||||||
| 5 | Limited Financial Capability | 0.025 | 1 | 0.025 | 2 | 0.050 | 5 | ||||||||||||||||||||
| 6 | Small company | 0.025 | 2 | 0.050 | 3 | 0.075 | 6 | ||||||||||||||||||||
| 7 | Informalities of Company | 0.050 | 1 | 0.050 | 2 | 0.100 | 7 | ||||||||||||||||||||
| 8 | Little Brand Recognition | 0.100 | 2 | 0.200 | 4 | 0.400 | 8 | ||||||||||||||||||||
| 9 | Collection Practices for receivables | 0.075 | 0 | 0.000 | 0 | 0.000 | 9 | ||||||||||||||||||||
| 10 | |||||||||||||||||||||||||||
| Total Weight: | 1.000 | 4.965 | 4.490 | Total Weight: | TAS: | TAS: | 0.000 | TAS: | 0.000 | TAS: | 0.000 |
Finance
| Data | Description | Data | Description | Data | Description | ||
| 10% | Annual discount rate | 10% | Annual discount rate | 10% | Annual discount rate | ||
| $ (10,000,000) | Initial cost of investment one year from today | $ (10,000,000) | Initial cost of investment one year from today | $ (10,000,000) | Initial cost of investment one year from today | ||
| $ 3,000,000 | Return (less costs) from first year | $ 3,000,000 | Return (less costs) from first year | $ 3,000,000 | Return (less costs) from first year | ||
| $ 4,200,000 | Return (less costs) from second year | $ 4,200,000 | Return (less costs) from second year | $ 4,200,000 | Return (less costs) from second year | ||
| $ 6,800,000 | Return (less costs) from third year | $ 6,800,000 | Return (less costs) from third year | $ 6,800,000 | Return (less costs) from third year | ||
| $ 4,000,000 | Total Return | $ 4,000,000 | Total Return | $ 4,000,000 | Total Return | ||
| $ 1,188,443 | NPV | 16% | IRR | $ 1,188,443 | NPV | ||
| 1.12 | PI | ||||||
| 8% | |||||||
| Year | Cash Flows | ||||||
| 0 | ($10,000) | ||||||
| 1 | $1,500 | ||||||
| 2 | $2,500 | ||||||
| 3 | $4,000 | ||||||
| 4 | $3,000 | ||||||
| 5 | $3,000 | ||||||
| 6 | $3,000 | ||||||
| $2,634.18 | npv | ||||||
| 1.26 | PI |
Example: TOYOTA MOTOR COMPANY
Birth Growth Maturity Revival Decline
Size of Company
Time
DAIAHATSU
TOYOTA
HINO
LEXUS
Overall Toyota is in “Late Stage” lifecyc le
with “Intense Competition.” This suggests
“Critical Problems” of a) Maintain market
position, b) Furthering its image via focus &
differentiation strategies and c) Cost
control
Exhibit 15.6